Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune-related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patients. | Mol Oncol | 2022 | 36209368 | PubTator, text mining | PubMed |
| Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study. | BMC Infect Dis | 2022 | 36209073 | PubTator, text mining | PubMed |
| Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis. | BMC Genomics | 2022 | 36209057 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| Single-Cell Immunobiology of the Maternal-Fetal Interface. | J Immunol | 2022 | 36192116 | PubTator, text mining | PubMed |
| Constructing a molecular subtype model of colon cancer using machine learning. | Front Pharmacol | 2022 | 36188575 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure. | Theranostics | 2022 | 36185612 | PubTator, text mining | PubMed |
| Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer. | Front Oncol | 2022 | 36185238 | PubTator, text mining | PubMed |
| FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration. | Front Oncol | 2022 | 36185230 | PubTator, text mining | PubMed |
| Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV. | iScience | 2022 | 36157576 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma. | Comput Math Methods Med | 2022 | 36148016 | PubTator, text mining | PubMed |
| PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer. | J Inflamm Res | 2022 | 36147688 | PubTator, text mining | PubMed |
| N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma. | Front Genet | 2022 | 36147503 | PubTator, text mining | PubMed |
| Skin proteomic analysis of immune activation associated with regression of melanoma metastases induced by diphencyprone. | JAAD Int | 2022 | 36147215 | PubTator, text mining | PubMed |
| The Immune Subtypes and Landscape of Advanced-Stage Ovarian Cancer. | Vaccines (Basel) | 2022 | 36146529 | PubTator, text mining | PubMed |
| Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing. | Pharmaceuticals (Basel) | 2022 | 36145301 | PubTator, text mining | PubMed |
| Leukotriene A4 Hydrolase and Hepatocyte Growth Factor Are Risk Factors of Sudden Cardiac Death Due to First-Ever Myocardial Infarction. | Int J Mol Sci | 2022 | 36142157 | PubTator, text mining | PubMed |
| Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment. | Cancers (Basel) | 2022 | 36139572 | PubTator, text mining | PubMed |
| Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment. | Cancers (Basel) | 2022 | 36139524 | PubTator, text mining | PubMed |
| Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. | Front Immunol | 2022 | 36131919 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=29